Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$22.3 - $37.39 $434,872 - $729,142
-19,501 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$25.68 - $35.59 $500,785 - $694,040
19,501 New
19,501 $676,000
Q1 2021

May 17, 2021

SELL
$38.94 - $50.85 $3.38 Million - $4.42 Million
-86,915 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$37.65 - $63.77 $934,849 - $1.58 Million
-24,830 Reduced 22.22%
86,915 $3.76 Million
Q3 2020

Nov 16, 2020

BUY
$52.76 - $74.49 $5.9 Million - $8.32 Million
111,745 New
111,745 $6.16 Million

Others Institutions Holding GBT

About Global Blood Therapeutics, Inc.


  • Ticker GBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,476,200
  • Market Cap $4.62B
  • Description
  • Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...
More about GBT
Track This Portfolio

Track Moore Capital Management, LP Portfolio

Follow Moore Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moore Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Moore Capital Management, LP with notifications on news.